Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

We aimed to review and synthesize results reporting on the maintenance efficacy of Aripiprazole in adults with bipolar I disorder. Aripiprazole is FDA approved for the acute and maintenance treatment of bipolar I disorder. Aripiprazole’s efficacy during the long-term treatment of bipolar disorder is...

Descripción completa

Detalles Bibliográficos
Autores principales: McIntyre, Roger S, Yoon, Jinju, Jerrell, Jeanette M, Liauw, Samantha S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104690/
https://www.ncbi.nlm.nih.gov/pubmed/21655345
http://dx.doi.org/10.2147/NDT.S13876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104690/
https://www.ncbi.nlm.nih.gov/pubmed/21655345
http://dx.doi.org/10.2147/NDT.S13876

Ejemplares similares